What is the likely diagnosis and initial work‑up for a 33‑year‑old woman with bilateral hypoechoic nodules inferior to the thyroid lobes, elevated intact parathyroid hormone, and normal serum calcium?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Likely Diagnosis: Normocalcemic Primary Hyperparathyroidism with Bilateral Parathyroid Adenomas

This 33-year-old woman most likely has normocalcemic primary hyperparathyroidism (PHPT), with the bilateral hypoechoic nodules inferior to the thyroid lobes representing enlarged parathyroid glands. The elevated PTH (88) with normal calcium defines this as a non-typical presentation of PHPT 1.

Diagnostic Reasoning

The anatomic location (inferior to thyroid lobes) and bilateral hypoechoic appearance on ultrasound are classic for parathyroid pathology. While PTH of 88 is only mildly elevated, this is inappropriate in the setting of normal calcium—in healthy individuals, PTH should be suppressed when calcium is normal 2.

Critical Differential Considerations

Before confirming normocalcemic PHPT, you must systematically exclude secondary causes of elevated PTH:

Initial Work-Up Algorithm

Step 1: Rule Out Secondary Hyperparathyroidism (Mandatory)

Measure 25(OH) vitamin D levels immediately 2. Vitamin D insufficiency/deficiency is the most common cause of secondary hyperparathyroidism and must be corrected before diagnosing PHPT. If deficient:

  • Correct vitamin D status
  • Recheck PTH after maintaining normal vitamin D levels for >6 months 2
  • Only then can you diagnose normocalcemic PHPT if PTH remains elevated

Assess calcium intake using a dietary questionnaire 2. Insufficient calcium intake commonly causes secondary hyperparathyroidism.

Check renal function (serum creatinine, eGFR) 1. Chronic kidney disease causes secondary hyperparathyroidism.

Review medications: bisphosphonates, diuretics, corticosteroids, lithium can all affect PTH interpretation 1.

Screen for malabsorption: history of bariatric surgery or chronic diarrhea 2.

Step 2: Confirm PHPT Biochemically

Calculate fractional excretion of calcium (FeCa) 2:

  • FeCa = (urinary calcium × plasma creatinine) / (urinary creatinine × plasma calcium)
  • FeCa >2% supports PHPT (distinguishes from familial hypocalciuric hypercalcemia)
  • FeCa ≤2% suggests alternative diagnosis

Measure 24-hour urinary calcium 1:

  • Thresholds: >6.25 mmol/24h (250 mg/24h) in women indicates hypercalciuria
  • Hypercalciuria increases kidney stone risk and may warrant surgery even with normal serum calcium

Consider ionized calcium measurement 2 if total calcium is high-normal, as this may reveal occult hypercalcemia.

Optional: Oral calcium loading test 2 if diagnosis remains uncertain after above workup. In PHPT, calcium loading causes hypercalcemia without PTH suppression.

Step 3: Assess Target Organ Damage

Once PHPT is biochemically confirmed, systematically screen for complications 1, 2:

Renal assessment (Grade A++):

  • Estimate GFR
  • Renal/urinary tract imaging: low-dose CT urography preferred over ultrasound 1 to detect nephrolithiasis or nephrocalcinosis
  • Screen for symptoms of kidney stones

Bone assessment (Grade A++):

  • DEXA scan of spine, hip, AND distal radius (the radius is critical in PHPT) 1
  • Consider spine X-rays or vertebral fracture assessment for asymptomatic vertebral fractures
  • Document any history of low-trauma fractures

Step 4: Genetic Screening Consideration

At age 33, consider genetic testing for hereditary PHPT 3. Up to 10% of PHPT cases are hereditary, and young age at presentation increases this likelihood. Test for MEN1, MEN2A, and CDC73 mutations if:

  • Age <40 years
  • Multiglandular disease (bilateral nodules suggest this)
  • Family history of endocrine tumors or hypercalcemia

Common Pitfalls to Avoid

Do not diagnose normocalcemic PHPT without excluding vitamin D deficiency first. This is the most common error—vitamin D deficiency causes secondary hyperparathyroidism that mimics PHPT 2.

Do not assume bilateral nodules mean benign disease. While rare, parathyroid carcinoma can present with normal calcium 4, 5, 6, though this typically shows marked PTH elevation later.

Do not skip the FeCa calculation. This single test distinguishes PHPT from familial hypocalciuric hypercalcemia, avoiding unnecessary surgery 2.

Do not forget the distal radius on DEXA. PHPT preferentially affects cortical bone, making the radius measurement essential 1.

Imaging for Surgical Planning (If Surgery Indicated)

If surgery becomes indicated after workup, parathyroid ultrasound is first-line, combined with either dual-isotope scintigraphy (123I/99mTc-Sestamibi) or 18F-Choline PET-CT 1. If these are inconclusive, refer to an expert center for MRI or 4D-CT 1.

When to Refer for Surgery

Surgery is recommended if 1:

  • Clinical consequences develop (fractures, kidney stones, symptomatic hypercalcemia)
  • Hypercalciuria is present (>6.25 mmol/24h in women)
  • Target organ damage on screening (osteoporosis, nephrolithiasis)

Given her young age (33), even asymptomatic disease may warrant surgery to prevent decades of cumulative bone and renal damage, though this requires multidisciplinary discussion 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.